Human antithrombin III. Carbohydrate components and associated glycolipid

Area of Science:

• Biochemistry
• Glycobiology
• Hematology

Background:

• Human antithrombin III is a crucial glycoprotein regulating blood coagulation.
• Understanding its composition is vital for comprehending its function and potential therapeutic applications.

Purpose of the Study:

• To characterize the carbohydrate and lipid components of human antithrombin III.
• To investigate the interaction between antithrombin III and beta-glucosylceramide.

Main Methods:

• Glycoprotein analysis to determine carbohydrate composition (N-acetylglucosamine, mannose, galactose, sialic acid).
• Enzymatic treatment (neuraminidase) to release sialic acid.
• Lipid extraction and identification techniques to isolate and characterize the glucose-containing component.
• Chromatographic methods to assess the separation of the glycolipid from antithrombin III.

Main Results:

• Human antithrombin III contains N-acetylglucosamine, mannose, galactose, and sialic acid in a specific molar ratio.
• Sialic acid was confirmed via neuraminidase treatment.
• A glucose-containing component, identified as beta-glucosylceramide, was tightly complexed with antithrombin III.
• The modified antithrombin III retained its thrombin inhibitory and heparin-binding activities.
• Beta-glucosylceramide could not be separated using standard purification methods.

Conclusions:

• Human antithrombin III is a glycoprotein associated with beta-glucosylceramide.
• Antithrombin III may function as a significant carrier for beta-glucosylceramide.
• The functional impact of this glycolipid complex on antithrombin III activity requires further investigation.